Immune-Onc Therapeutics, Inc. — Form D
Immune-Onc Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-21. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-09-21
- Form: D
- Accession: 0001685307-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Minimum investment: $1
- Investors: 14
- Date of first sale: 2016-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-271031
Issuer
- Name: Immune-Onc Therapeutics, Inc.
- CIK: 0001685307
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1059 EAST MEADOW CIRCLE, PALO ALTO, CA, 94303
- Phone: 650-460-8898
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Xiaoling Charlene Liao | Director | Palo Alto, CA |
| Liqun Luo | Director | Palo Alto, CA |
| Guo-Liang Yu | Director | Palo Alto, CA |
| Xiaoling Charlene Liao | Executive Officer | Palo Alto, CA |
More